RPG Life Sciences Ltd - 532983 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
We are enclosing herewith certificate dated October 11, 2021 issued by Link Intime India Private Limited, Registrar and Share Transfer Agents, confirming compliance under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018. Kindly take the same on record. RPG LIFE SCIENCES LTD. - 532983 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
We wish to inform you that on October 10, 2021, we have received an application for loss of share certificate through Link Intime India Private Limited. A copy of email received from RTA is enclosed herewith for your reference. Kindly take the same on record. RPG LIFE SCIENCES LTD. - 532983 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Please find enclosed herewith intimation of issuance of duplicate share certificate as received by us from Link Intime Private Limited, our Registrar and Share Transfer Agent, being submitted to you pursuant to Regulation 39(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. Kindly take the same on record. RPG LIFE SCIENCES LTD. - 532983 - Closure of Trading Window
This is to inform you that pursuant to the 'Code of Fair Disclosure, Internal Procedures and Conduct for Regulating, Monitoring and Reporting of Trading by Insiders' of the Company and the SEBI (Prohibition of Insider Trading) Regulations, 2015, the Trading Window for dealing in Securities of the Company by Designated Persons and their immediate relatives shall remain closed from Friday, October 1, 2021 until 48 hours after the declaration of unaudited financial results by the Company for the quarter and half year ending on September 30, 2021. The date of Board Meeting of the Company for consideration and declaration of the unaudited financial results for the quarter and half year ending on September 30, 2021 will be intimated in due course. Kindly take this information on record.
RPG Life Sciences hits record high, zooms 51% so far in September
The domestic formulations business of the company will continue to focus on building chronic therapies, expanding specialty portfolio and life cycle management of current legacy products RPG Life Sciences Ltd - 532983 - Clarification On Price Movement
With reference to your above referred email dated September 9, 2021 seeking clarification on significant movement in the price of shares of the Company on your Exchange in the recent past, we hereby inform you that there is no event, information/announcement (including impending announcement) to be made by the Company which, in our opinion, may have a bearing on the price behaviour of the scrip and which is required to be disclosed under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 ("Listing Regulations"). Further, we would like to reiterate that, as in the past, the Company would continue to inform stock exchanges regularly about any price sensitive information and to make it available on the website of the Company before the same is made public. Kindly request you to take the same on record. RPG LIFE SCIENCES LTD. - 532983 - Clarification sought from RPG Life Sciences Ltd
The Exchange has sought clarification from RPG Life Sciences Ltd on September 9, 2021 with reference to significant movement in price, in order to ensure that investors have latest relevant information about the company and to inform the market so that the interest of the investors is safeguarded.The reply is awaited. RPG LIFE SCIENCES LTD. - 532983 - Disclosure of Voting results of AGM (Regulation 44(3) of SEBI (LODR) Regulations, 2015)
RPG Life Sciences Ltd has informed BSE regarding the details of Voting results of AGM, under Regulation 44(3) of SEBI (LODR) Regulations, 2015. Kindly Click here RPG Life Sciences Ltd - 532983 - Shareholder Meeting / Postal Ballot-Scrutinizer''s Report
Pursuant to Regulation 30 read with Para A of Part A in Schedule III of the Listing Regulations, we enclose herewith the brief proceedings of the Fourteenth Annual General Meeting (AGM) of the Company held on Tuesday, August 31, 2021 at 3:00 p.m. as Annexure A. Further, pursuant to Regulation 44(3) of the Listing Regulations and Section 108 of the Companies Act, 2013 read with Rule 20 of the Companies (Management and Administration) Rules, 2014, we are also submitting herewith the details regarding the voting results of the business transacted at the AGM in the prescribed format along with the Consolidated report of the Scrutinizer as Annexure B and Annexure C respectively. All the resolutions at AGM were passed with requisite majority. You are requested to take the same on record. RPG Life Sciences Ltd - 532983 - Shareholder Meeting / Postal Ballot-Outcome of AGM
Pursuant to Regulation 30 read with Para A of Part A in Schedule III of the Listing Regulations, we enclose herewith the brief proceedings of the Fourteenth Annual General Meeting (AGM) of the Company held on Tuesday, August 31, 2021 at 3:00 p.m. as Annexure A. Further, pursuant to Regulation 44(3) of the Listing Regulations and Section 108 of the Companies Act, 2013 read with Rule 20 of the Companies (Management and Administration) Rules, 2014, we are also submitting herewith the details regarding the voting results of the business transacted at the AGM in the prescribed format along with the Consolidated report of the Scrutinizer as Annexure B and Annexure C respectively. All the resolutions at AGM were passed with requisite majority. You are requested to take the same on record.